Percutaneous/transdermal delivery of ASA and antithrombotic therapies based thereon
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 4, 1999
Grant Date -
N/A
app pub date -
Apr 25, 1997
filing date -
Apr 25, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Topically applicable pharmaceutical/therapeutic alcoholic solution compositions, well suited for percutaneous/transdermal antithrombotic therapy, comprise an effective antithrombotic amount of acetylsalicylic acid ('ASA') or salt thereof, formulated into primary alcohol (e.g., isopropanol) and secondary ester (e.g., isopropyl myristate) solvents therefor, optionally in the presence of penetration enhancers and/or ASA hydrolysis inhibitors.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully